Genentech is a paid sponsor of The Morning Blend
Millions of people in the United States live with eye conditions that can cause blindness if left untreated. Dr. Ivan Suñer talks about a first-of-its-kind medicine to treat the two leading causes of blindness.
Millions of people in the United States live with eye conditions that can cause blindness if left untreated. These include wet age-related macular degeneration (AMD) and diabetic macular edema (DME). In fact, they are two leading causes of vision loss in the U.S. when left untreated.
Did you know?
- More than 1 million people have wet AMD, which impacts central vision needed for activities like reading and driving.[i]
- People with diabetes are at risk of DME, a vision-threatening retinal condition that affects approximately 750,000 people in the U.S. This number is expected to grow as the prevalence of diabetes increases.[ii]
The U.S. Food and Drug Administration recently approved a first-of-its-kind injectable eye treatment for these conditions that works in two ways and can be given on a flexible dosing schedule based on patient need. Treatments may be given from one to four months apart in the first year after four monthly doses, based on a physician’s evaluation of the patient’s anatomy and vision outcomes.
For more information visit:
